Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- article scientifique publié en 2019 (fr)
- artículu científicu espublizáu n'avientu de 2019 (ast)
- 2019 թվականի դեկտեմբերի 10-ին հրատարակված գիտական հոդված (hy)
- scientific article published on 10 December 2019 (en)
- наукова стаття, опублікована 10 грудня 2019 (uk)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Yannick Allanore
- Maureen D Mayes
- Yue Wang
- Cathie Spino
- Flavia V Castelino
- Nora Sandorfi
- David A Fox
- Robert Lafyatis
- Virginia D Steen
- Michael L Whitfield
- Robert W Simms
- Amber Young
- Daniel E Furst
- Elena Schiopu
- Lorinda Chung
- Vivien Hsu
- Veronica Berrocal
- Faye N Hant
- Ora Singer
- Jane Park
- Suzanne Kafaja
- Robyn T Domsic
- Jerry Molitor
- Ali Ajam
- Erica Bush
- Sindhu Johnson
- Anna Gill
- Tammara Wood
- Bhavan Mehta
|
rdfs:label
| - Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (en)
- Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (nl)
|
skos:prefLabel
| - Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (en)
- Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (nl)
|
name
| - Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (en)
- Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (nl)
|
author
| |
author
| |
title
| |
title
| - Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |